Article Details

RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 ...

Retrieved on: 2021-11-15 18:07:36

Tags for this article:

Click the tags to see associated articles and topics

RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 .... View article details on hiswai:

Excerpt

RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up